NEW YORK (GenomeWeb News) — Affymetrix and the Children’s Research Institute in Wisconsin will use Affy’s GeneChip technology to identify genetic variations linked to common, complex childhood diseases, Affy said today.
 
CRI, a non-profit medical research arm of the Children's Hospital and Health System affiliated with the Medical College of Wisconsin, intends to use the data from the large-scale studies to develop diagnostics, and to “show the clinical utility of array-based molecular diagnostics,” Affy said. 
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Kite Pharmaceuticals' CAR T-cell therapy for large B-cell lymphomas, the New York Times reports.

Kaiser Health News reports that gene therapies could cost more than a million dollars.

Worcester Polytechnic Institute researchers have received a grant to combine biology and computer science for high school students.

In Nature this week: variants associated with obsessive-compulsive disorder, review of key CRISPR enzymes, and more.